No Data
Repare Therapeutics Shares Drop 38% Following Phase 1 Trial Results
US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings
Express News | Repare Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Down - 47.4%
Wall Street Set to Open Higher Friday as Investors Shake Off Bad Week
Repare Therapeutics Reports Positive Data From MYTHIC Phase 1 Trial And Plans For Phase 3 In 2025
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Investors Eye Third Rate Cut
Jaguar8 : I did my research on platinum resistant ovarian ca and typical PFS is 3-4 months so this >7 months is good. The endometrial cancer was not much specified on its type
TranceHead : @Jaguar8 @Trytosaveabit i think because digital media made trading so easy, it's too easy for people who can't properly read a PR or announcement to trade. so we get dumb shit happen